Lawmakers Target FDA Along With Mylan CEO at Congressional EpiPen Hearing


Stephen Ryan accompanied Mylan chief executive officer Heather Bresch for House Oversight Committee hearings on the company’s EpiPen pricing. Mr. Ryan represented Mylan in its communications with the Senate Judiciary Committee to « correct the many misperceptions in the public dialogue about Mylan and this product, » and the letter foreshadowed points that Bresch highlighted in the hearing.